Children's Research Institute

CTSICN

Mission Statement

The mission of the CTSI-CN is to foster broad collaborative investigation that accelerates discovery and drives dialogue across the bench, bedside, and community continuum.

At a Glance

0

Educational Resources Posted

1

Consortium News Stories Posted

2

Events Posted

0

Opportunities Posted

Coming Soon

Publications citing CTSA Program Grant

23

Users from Hub Registered
Contact PI Organization
Other Organizations
Programs

UL1 Award

KL2 Award

TL1 Award

Funded Years
2012 - 2020
Connect with Us

Educational Content

DC CTSA Consortium 2020 Spring Regulatory Update & Hot Topics in Clinical Research Archives

This annual meeting brings researchers, administrators, and clinical professionals from throughout the Clinical and Translational Sciences Awards (CTSA) region together for collaborative discussion and response to regulatory revisions and identified clinical research priorities within the current

CN-NIAID Virtual Symposium 2020

3rd Annual Children's National - NIAID Virtual Symposium

A one day virtual symposium bringing together investigators, researchers, and clinicians from National Institute of Allergy and Infectious Diseases (NIAID) and Children’s National Hospital as well as other interested participants from outside institutions, to discuss the creation, progress, and

DC CTSA Announcement Banner

COVID-19: the Virus, Preparedness in the time of Crisis, and Clinical Research

This annual meeting brings researchers, administrators, and clinical professionals from throughout the Clinical and Translational Sciences Awards (CTSA) region together for collaborative discussion and response to regulatory revisions and identified clinical research priorities within the current

2019 Annual Children's National–NIAID Symposium

We are excited to invite you to the 2nd Annual Children's National-NIAID Symposium! The Children's National and the National Institute of Allergy and Infectious Diseases (NIAID) partnership focuses on pediatric studies of significant interest to investigators at both institutions. This collaboration

Virtual Device Accelerator (ViDA)

Who We Are: We serve as a national level virtual accelerator, providing a platform of experienced regulatory, prototyping, clinical trials design, and commercialization to support CTSA investigators to validate early-stage device concepts addressing an unmet medical need. We source and scout ideas

Funding opportunity 2020

The Myasthenia Gravis Rare Disease Network, MGNet (U54 NS115054), announces its request for applications to two of its programs

The National Institutes of Health (NIH) awarded a research team at George Washington (GW), Yale, and Duke Universities $7.8 million to establish a rare disease network for Myasthenia Gravis. The team is led by Henry Kaminiski, MD (GW) and includes Linda Kusner, PhD (GW), Alison Hall, PhD (GW)